We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients.
- Authors
Low, David Alvin; Xu, Jennifer; Tibrewal, Prashant; Bastiampillai, Tarun; Dhillon, Rohan
- Abstract
The article presents a case study of a 65-year-old man with a mild intellectual disability with catatonic symptoms like decreased responsiveness and negativistic phenomena. Topics discussed include use of oral lorazepam and clonazepam for treatment of catatonia; use of electroconvulsive therapy (ECT); and use of parenteral lorazepam first-line treatment for catatonia.
- Subjects
AUSTRALIA; CATATONIA; SUBCUTANEOUS injections; CLONAZEPAM; DIAGNOSIS; ELECTROCONVULSIVE therapy; LORAZEPAM; MEDICAL errors; PEOPLE with intellectual disabilities; MOVEMENT disorders; PEOPLE with disabilities
- Publication
Australian & New Zealand Journal of Psychiatry, 2017, Vol 51, Issue 2, p198
- ISSN
0004-8674
- Publication type
Case Study
- DOI
10.1177/0004867416656806